When Alonso Zepeda, senior manager, Corporate Affairs, shared information at a news conference about a Bristol Myers Squibb program that trains tattoo artists in Mexico to look for signs of melanoma on their clients, some of the journalists were confused.
“They were like, ‘Why are you interested in this? You’re talking about prevention, not treatment,’” Zepeda recalled.
The answer was easy for Zepeda. Advocacy programs like Look for the Spot are an integral part of the company’s commitment to the communities it serves — a way to offer innovative approaches to help people get and stay healthy beyond medications.
Each year, BMS celebrates Global Patient Week to honor patients, who are at the center of the company’s heart and advocacy mission. To show that science and medicine have the potential to give people more time, to make more memories.
This year marks the ninth year for the patient-centered event, a commitment that reaches around the world. And patient advocacy programs are an important part of that reach.
Jasmine Greenamyer, executive director of Global Patient Advocacy, said BMS is one of the first companies to establish the weeklong effort.
“At BMS, we’re very mindful about putting patients at the center of what we do,” she said. "Partnering with the patient community is an essential investment for realizing our mutual goals."
Advocating for patients
Matt Alsante, senior director of Patient Advocacy, Hematology, said it’s vital to include the patient perspective into everything the company does.
“Being committed to patient advocacy means being an active participant in supporting the patient on their entire journey,” he said. “From the research and development of new therapies all the way to the commercialization of medicines, it has become increasingly important.”
His work revolves around establishing long-term partnerships with patient advocacy organizations, working to better identify patients’ unmet needs and supporting the growth of trusted programs that support those needs. It also means forming innovative collaborations with professionals who are trusted by their clients.
“I always say, getting to focus on patient advocacy is the best job in the pharmaceutical industry,” said Alsante, who has spent 25 years working in the patient advocacy nonprofit space.
He understands the importance of having accurate, up-to-date information for patients and their caregivers, which advocacy groups can provide. “Unfortunately, the internet is a sea of misinformation,” he said.